Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Vanda Pharmaceuticals Inc. (VNDA) had Weighted-Average Shares Outstanding (Diluted) of 58.15M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$53.19M |
|
$-4.91M |
|
$2.59M |
|
$50.59M |
|
$63.46M |
|
$-10.28M |
|
$3.78M |
|
$-6.50M |
|
$-6.50M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-4.91M |
|
$-10.28M |
|
$-9.82M |
|
58.15M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
58.15M |
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$438.89M |
|
$2.13M |
|
$217.31M |
|
$656.20M |
|
$99.98M |
|
-- |
|
$17.68M |
|
$117.66M |
|
$538.55M |
|
$424.45M |
|
$538.55M |
|
58.31M |
|
| Cash Flow Statement Financials | |
$-15.76M |
|
$-17.43M |
|
$-0.15M |
|
$136.29M |
|
$102.78M |
|
$-33.51M |
|
$12.43M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
95.13% |
|
-19.33% |
|
-19.33% |
|
-- |
|
-12.22% |
|
-9.24% |
|
$-20.48M |
|
-- |
|
-- |
|
-- |
|
0.08 |
|
1.50 |
|
1.13 |
|
79.70 |
|
-0.91% |
|
-1.16% |
|
-0.75% |
|
-0.91% |
|
$9.24 |
|
$-0.35 |
|
$-0.27 |
|